TB
Tony Butler Rodman & Renshaw Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
|
GNTA
26
Genenta Science
GNTA
$62.9M
| $3.42 | $15 |
339%
upside
| Buy |
5 Jan ‘23
2 years ago |
|
27
Marker Therapeutics
MRKR
$11.3M
| $0.8510 | $10 |
1,075%
upside
| Neutral |
17 Feb ‘22
3 years ago |
|
28
Compass Therapeutics
CMPX
$590M
| $3.48 | $15 |
331%
upside
| Buy |
19 Nov ‘21
3 years ago |
|
29
BioAtla
BCAB
$35.9M
| $0.7131 | $75 |
10,417%
upside
| Buy |
28 Jun ‘21
4 years ago |
|
30
Intellia Therapeutics
NTLA
$1.27B
| $11.88 | $110 |
826%
upside
| Buy |
28 Jun ‘21
4 years ago |
|
31
GT Biopharma
GTBP
$3.07M
| $0.7477 | $750 |
100,208%
upside
| Buy |
17 Mar ‘21
4 years ago |
|
32
CRISPR Therapeutics
CRSP
$4.92B
| $53.69 | $170 |
217%
upside
| Buy |
7 Dec ‘20
4 years ago |
|
33
Allogene Therapeutics
ALLO
$253M
| $1.14 | $60 |
5,163%
upside
| Buy |
19 May ‘20
5 years ago |
|
34
Compugen
CGEN
$136M
| $1.43 | $28 |
1,858%
upside
| Buy |
22 Apr ‘20
5 years ago |
|
35
NextCure
NXTC
$13.2M
| $5.07 | $960 |
18,835%
upside
| Buy |
2 Mar ‘20
5 years ago |
|